Indian biotech startups grew from 50 in 2014 to 8,531 in 2023: Jitendra Singh

48

New Delhi, March 12 (IANS) The number of biotech startups in the country has grown from 50 in 2014 to 8,531 in 2023, said Jitendra Singh, Minister of State (Independent Charge) for Ministry of Science and Technology on Wednesday.

Singh said this in a written reply in the Lok Sabha today citing the India BioEconomy Report (IBER) 2024.

The number of biotech startups grew steadily from just 50 (2014) to 732 (2015) to 1,022 (2016) to 1,732 (2017), 2,662 (2018), 3,397 (2019), and 4,237 (2020).

It grew even through the Covid-19 pandemic years — in 2021 the number of startups stood at 5,365, jumping to 6,755 in 2022 and 8,531 in 2023, the report showed.

Singh informed that to nurture and strengthen the start-up ecosystem in the country with a focus on the biotech sector, the Department of Biotechnology (DBT) established the Biotechnology Industry Research Assistance Council (BIRAC) in 2012.

BIRAC serves as an interface agency addressing nationally relevant product development needs. It follows and aligns its activities in line with the National Policies announced by the Government from time to time.

BIRAC supports the biotech start-up ecosystem by establishing bio-incubators through various funding schemes, which include Equity Funding Schemes, Amrit Grand Challenge, and BioE3 Policy among others. It has to date “established 95 centres”, Singh said.

“BIRAC schemes and programmes are regularly assessed internally and updated in line with the evolving needs of the ecosystem. New programmes are launched as and when required. BIRAC also partners with several national and international agencies ensuring continuous support for the biotech start-up ecosystem,” the MoS said.

The DBT has recently launched the BioE3 policy with the approval of the Cabinet for the development of bio-based products through the setting up of BioEnablers that include Bio-Artificial Intelligence (Bio-AI) hubs, biofoundries, and biomanufacturing hubs across the country.

DBT and BIRAC announced a joint call inviting proposals for setting up ‘BioEnablers – Biofoundries and Biomanufacturing Hubs’, in both academia and industry.

“From over 253 applications, 24 projects on biofoundries and biomanufacturing hubs have been recommended for support,” Singh said. These are being established across the country with a two-year duration.

Further plans for setting up bio-AI hubs and biomanufacturing facilities are also under process, he added.

–IANS

rvt/

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

MGID